← Eichor
Study identifier: NCT06844448 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

The Effect of Different Risk Factors on the Success Rate of VPT

Condition: Dental Caries Extending to Pulp · Pulp Disease, Dental · Irreversible Pulpitis  ·  Sponsor: Semmelweis University

PhaseN/A
Planned participants400
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This study aims to evaluate the effectiveness of various vital pulp therapy (VPT) methods, such as direct pulp capping, partial pulpotomy, and total pulpotomy, in maintaining pulp vitality following pulp exposure. It explores the success rates of these treatments compared and investigates co-factors influencing these rates, including age. This prospective cohort study involves patients over 18 with restorable teeth and exposed pulp chambers. Success is measured through clinical and radiological criteria over a follow-up period of up to four years. The study also aims to identify if there's an age threshold affecting the preference for VPT over root canal therapy.

This description comes directly from the study's public registry record.

Talk to the study team

Melinda Zs Polyák, DMD  ·  +36 1 459 1500  ·  polyak.melinda@semmelweis.hu

Always discuss trial participation with your own doctor first.

Locations (1)

Department for Restorative Dentistry and Endodontics, Semmelweis UniversityBudapest, HungaryRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06844448